MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: Cardiovascular, Cardiac & Cardiology Companies _ Heart Valves, Ventricular Assist (LVAD,pVAD), Artificial Heart
Foldax
Attachments
Home | Tria Valve by Foldax
Parents
*Architects: Cardiovascular, Cardiac & Cardiology Companies _ Heart Valves, Ventricular Assist (LVAD,pVAD), Artificial Heart
2020: Fierce Medtech's 2020 Fierce 15
Venture Capital: Series D
Children
2021: _Fierce 15
Foldax is working on a next-gen heart valve alongside new manufacturing processes that tap robotic technology to make production more efficient and pandemic-proof.
Founded 2013
Frank Maguire, CEO, Foldax (2021)
Investors: Foldax raised a $20 million Series D round in 2020 led by MemorialCare Innovation Fund, with additional contributions from the Angel Physicians Fund, Sayan Bioventures, BioStar Capital, Kairos Ventures and Caltech
Salt Lake City, Utah
Tria™ heart valves are made with revolutionary new LifePolymer™ material and designed to last a lifetime
Jumps
CalTech (California Institute of Technology)